Octagon Capital Advisors »

Cogent Biosciences shares owned by Octagon Capital Advisors

Quarter-by-quarter ownership of Cogent Biosciences (COGT) shares owned by Octagon Capital Advisors from 13F filings

Historical chart of Octagon Capital Advisors investment in Cogent Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cogent Biosciences held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cogent Biosciences by Octagon Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $14M 1.3M 10.80

More positions owned by Octagon Capital Advisors

Apellis Pharmaceuticals (APLS)
Verona Pharma Sponsored Ads (VRNA)
Structure Therapeutics Sponsored Ads (GPCR)
Insmed Com Par $.01 Call Option (INSM)
Dianthus Therapeutics (DNTH)
Arrivent Biopharma (AVBP)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Nuvation Bio Com Cl A (NUVB)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Ocular Therapeutix (OCUL)
Miragen Therapeutics (VRDN)
Perspective Therapeutics Com New (CATX)
Mind Medicine Mindmed Com New (MNMD)
Cogent Biosciences (COGT)
Bridgebio Pharma (BBIO)

View all positions for Octagon Capital Advisors

Top funds holding Cogent Biosciences

Point72 Asset Management
Kynam Capital Management
BlackRock
Commodore Capital
BlackRock
TCG Crossover Management
Fairmount Funds Management
VR Adviser
Vanguard Group
Paradigm Biocapital Advisors
Redmile Group
State Street Corporation
Deerfield Management Company
Geode Capital Management
Sofinnova Ventures

View all funds holding Cogent Biosciences